Audit (A-03-08-00011)

09-22-2009
Review of Medicare Part D Drug Payments to Baron Drug Company for Service Dates January 1 – March 31, 2006

Executive Summary

Baron Drug Company received improper payments of at least $79,000 from New Jersey, which the Centers for Medicare & Medicaid Services reimbursed under the “Reimbursement of State Costs for Provision of Part D Drugs” Medicare demonstration project.

Complete Report

Notification Download the complete report (PDF)
Adobe Acrobat Reader This link exits the Office of Inspector General Web site is required to view PDF files.

Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.